Low toxicity of high-dose CTM followed by autologous stem cell reinfusion for high-risk breast cancer

被引：0

作者：

Kruger, WH ^{[1
]}

Kroger, N ^{[1
]}

Kolbe, K ^{[1
]}

Huber, C ^{[1
]}

Gieseking, F ^{[1
]}

Janicke, F ^{[1
]}

Konigsmann, M ^{[1
]}

Berdel, WE ^{[1
]}

Kerschgens, C ^{[1
]}

Mayr, AC ^{[1
]}

Schafer-Eckert, K ^{[1
]}

Wandt, H ^{[1
]}

Schultze, W ^{[1
]}

Fuss, H ^{[1
]}

Metzner, B ^{[1
]}

Illiger, HJ ^{[1
]}

Frickhofen, N ^{[1
]}

Mobus, V ^{[1
]}

Hossfeld, DK ^{[1
]}

Jonat, W ^{[1
]}

Zander, AR ^{[1
]}

机构：

[1] Univ Hamburg, Hosp Eppendorf, Dept Oncol Haematol, BMT Unit, D-20246 Hamburg, Germany

来源：

BONE MARROW TRANSPLANTATION | 1998年 / 21卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

221

引用

页码：S62 / S62

页数：1

共 50 条

[1] CUTANEOUS TOXICITY OF HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION
BEYER, J
GRABBE, J
LENZ, K
WEISBACH, V
STROHSCHEER, I
HUHN, D
SIEGERT, W
BONE MARROW TRANSPLANTATION, 1992, 10 (06) : 491 - 494
[2] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
Tallman, MS
Gradishar, WJ
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S60 - S67
[3] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
Martin S. Tallman
William J. Gradishar
Cancer Chemotherapy and Pharmacology, 1998, 42 : S60 - S67
[4] Consolidation with high-dose chemotherapy followed by reinfusion of autologous CD34+positively selected stem cells in inflammatory and high-risk breast cancer patients
Lakota, J
Ladicka, M
Ballova, V
Vranovsky, A
BONE MARROW TRANSPLANTATION, 2004, 33 : S358 - S358
[5] High-dose chemotherapy followed by autologous stem cell transplantation in non-metastatic high-risk breast cancer: a systematic review
Herrmann-Frank, A.
Sturtz, S.
Lerch, C.
Richter, B.
Bartel, C.
Droste, S.
Lange, S.
BONE MARROW TRANSPLANTATION, 2011, 46 : S87 - S87
[6] HIGH-DOSE CISPLATIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS STEM-CELL REINFUSION IN PATIENTS WITH RESPONSIVE METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER
SOMLO, G
DOROSHOW, JH
FORMAN, SJ
LEONG, LA
MARGOLIN, KA
MORGAN, RJ
RASCHKO, JW
AKMAN, SA
AHN, C
SNIECINSKI, I
CANCER, 1994, 73 (01) : 125 - 134
[7] HIGH-DOSE DOXORUBICIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH STEM-CELL REINFUSION IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER
SOMLO, G
DOROSHOW, JH
FORMAN, SJ
LEONG, LA
MARGOLIN, KA
MORGAN, RJ
RASCHKO, JW
AKMAN, SA
AHN, C
NAGASAWA, S
HARRISON, J
STEIN, A
SMITH, E
SNIECINSKI, I
SCHMIDT, GM
CANCER, 1994, 73 (06) : 1678 - 1685
[8] Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma
Uemura, Suguru
Mori, Takeshi
Ishiko, Shinya
Takafuji, Satoru
Nino, Nanako
Yamamoto, Nobuyuki
Hayakawa, Akira
Nishimura, Noriyuki
Hara, Hitomi
Kawamoto, Teruya
Akisue, Toshihiro
Iijima, Kazumoto
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (04) : 337 - 343
[9] Pharmacokinetics of thiotepa and mitoxantrone in high-dose chemotherapy with autologous stem cell support of patients with high-risk breast cancer
Wolkewitz, B
Hilger, RA
Skorzec, M
Markus-Matulla, A
Mayer, S
Steiniger, H
Schneemann, H
Seeber, S
Scheulen, ME
BONE MARROW TRANSPLANTATION, 1998, 22 : S60 - S64
[10] High-dose chemotherapy followed by autologous stem reinfusion in patients with advanced breast cancer: a single-centre retrospective evaluation
Musso, M
Porretto, F
Crescimanno, A
Polizzi, V
Scalone, R
BONE MARROW TRANSPLANTATION, 2004, 33 : S359 - S359

← 1 2 3 4 5 →